Apoptosis
Research Areas
Products Related to Apoptosis(675)
- GC79047HDAC6-IN-75CAS: 400078-78-6Purity: >99.50%
HDAC6-IN-75 is a selective HDAC6 inhibitor with an IC 50 of 0.17 nM against HDAC6.
- GC79048HDAC1/3-IN-1CAS: 244289-53-0Purity: >99.50%
HDAC1/3-IN-1 is a selective HDAC1/3 inhibitor, with IC 50 values of 256 nM and 340.3 nM against HDAC1 and HDAC3, respectively.
- GC79058PARP1/NAMPT-IN-1CAS: 3084810-86-3Purity: >98.00%
PARP1/NAMPT-IN-1 is a potent and dual PARP1 and NAMPT inhibitor with IC 50 values of 1.2 nM and 6.7 nM, respectively.
- GC79067ADAR1i-124Purity: >98.50%
ADAR1i-124 is an A-to-I RNA editing inhibitor by inhibiting the catalytic activities of both ADAR1p150 and ADAR1p110.
- GC79070WWQ-03-012CAS: 3076807-15-0Purity: >98.00%
WWQ-03-012 is a selective DESI2 inhibitor with an IC 50 of 47.3 nM.
- GC79103Berzosertib hydrochlorideCAS: 1428935-04-9Purity: >98.50%
Berzosertib (VE-822) hydrochloride is an orally active, CNS-penetrant, and selective ATR kinase inhibitor.
- GC79109CZS-241 hydrochloridePurity: >98.50%
CZS-241 hydrochloride is an orally active and selective inhibitor of Polo-like Kinase 4 ( PLK4 ) ( IC 50 =2.6 nM).
- GC79141T7 Peptide TFAPurity: >98.00%
T7 Peptide TFA is a protein synthesis inhibitor and anti-angiogenic agent, with a K d of 10 nM for human transferrin receptor.
- GC79143BRD4-IN-12CAS: 3112325-99-9Purity: >98%
BRD4-IN-12 is a potent and orally active BRD4 inhibitor with an IC 50 of 7.9 nM.
- GC79195Semaglutide-FITCPurity: >96.50%
Semaglutide -FITC (Semaglutide-Lys(FITC)) is a fluorescent tracer probe (Ex/Em = 495/520 nm) obtained by covalently coupling the green fluorescent dye fluorescein isothiocyanate (FITC) to the long-acting analogue of GLP-1, Semaglutide.
- GC79196Semaglutide, Cy5 labeledPurity: >98%
Semaglutide, Cy5-labeled (Semaglutide-Cys(Cy5)) is a CY5 -labeled version of Semaglutide (Ex/Em = 633/670 nm).
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC79047 | HDAC6-IN-75 | 400078-78-6 | >99.50% | |
HDAC6-IN-75 is a selective HDAC6 inhibitor with an IC 50 of 0.17 nM against HDAC6. | ||||
| GC79048 | HDAC1/3-IN-1 | 244289-53-0 | >99.50% | |
HDAC1/3-IN-1 is a selective HDAC1/3 inhibitor, with IC 50 values of 256 nM and 340.3 nM against HDAC1 and HDAC3, respectively. | ||||
| GC79049 | CG-1521 | 674767-29-4 | >95.50% | |
CG-1521 is a histone deacetylase ( HDAC ) inhibitor that stabilizes Ac-Lys373 P53, increases P21 levels and HDAC2 degradation. | ||||
| GC79050 | OUL312 | - | >99.00% | |
OUL312 is a potent PARP10 inhibitor ( IC 50 = 20 nM), showing more than 75-fold greater selectivity for PARP15 ( IC 50 = 1500 nM). | ||||
| GC79057 | BF-175 | 1333375-02-2 | >98% | |
BF-175 is a selective SIRT1 agonist. | ||||
| GC79058 | PARP1/NAMPT-IN-1 | 3084810-86-3 | >98.00% | |
PARP1/NAMPT-IN-1 is a potent and dual PARP1 and NAMPT inhibitor with IC 50 values of 1.2 nM and 6.7 nM, respectively. | ||||
| GC79067 | ADAR1i-124 | - | >98.50% | |
ADAR1i-124 is an A-to-I RNA editing inhibitor by inhibiting the catalytic activities of both ADAR1p150 and ADAR1p110. | ||||
| GC79070 | WWQ-03-012 | 3076807-15-0 | >98.00% | |
WWQ-03-012 is a selective DESI2 inhibitor with an IC 50 of 47.3 nM. | ||||
| GC79072 | MS6076 | - | >98% | |
MS6076 is a mitochondrial protease ClpP agonist. | ||||
| GC79077 | DDO-6600 | 2640292-37-9 | >98.00% | |
DDO-6600 is a covalent Hsp90 inhibitor. | ||||
| GC79103 | Berzosertib hydrochloride | 1428935-04-9 | >98.50% | |
Berzosertib (VE-822) hydrochloride is an orally active, CNS-penetrant, and selective ATR kinase inhibitor. | ||||
| GC79109 | CZS-241 hydrochloride | - | >98.50% | |
CZS-241 hydrochloride is an orally active and selective inhibitor of Polo-like Kinase 4 ( PLK4 ) ( IC 50 =2.6 nM). | ||||
| GC79111 | CK2-TN03 | 313226-24-3 | >98.00% | |
CK2-TN03 is an ATP-competitive casein kinase 2 ( CK2 ) inhibitor, with an IC 50 of 165 nM and a K i of 20 nM. | ||||
| GC79122 | Opitor-0 | - | >98.00% | |
Opitor-0 is a OPA1 GTPase inhibitor with an IC 50 of 3.0 μM. | ||||
| GC79141 | T7 Peptide TFA | - | >98.00% | |
T7 Peptide TFA is a protein synthesis inhibitor and anti-angiogenic agent, with a K d of 10 nM for human transferrin receptor. | ||||
| GC79143 | BRD4-IN-12 | 3112325-99-9 | >98% | |
BRD4-IN-12 is a potent and orally active BRD4 inhibitor with an IC 50 of 7.9 nM. | ||||
| GC79144 | MC3817 free base | - | >98% | |
MC3817 free base is a selective DNMT1 inhibitor. | ||||
| GC79145 | MC3817 | - | >99.50% | |
MC3817 is a selective DNMT1 inhibitor. | ||||
| GC79146 | Ischemin | 1357059-00-7 | >99.50% | |
Ischemin is a CBP bromodomain inhibitor that inhibits p53 interaction with CBP and transcriptional activity in cells. | ||||
| GC79147 | HLC40 | - | >99.50% | |
HLC40 is a MLL1 histone methyltransferase inhibitor with an IC 50 of 0.82 μM by binding to WDR5. | ||||
| GC79148 | ZINC13000658 | 1324070-76-9 | >99.50% | |
ZINC13000658 is a METTL inhibitor. | ||||
| GC79194 | Exendin-4-Cys | - | >99.50% | |
Exendin-4 -Cys is a cysteine-modified Exendin-4. | ||||
| GC79195 | Semaglutide-FITC | - | >96.50% | |
Semaglutide -FITC (Semaglutide-Lys(FITC)) is a fluorescent tracer probe (Ex/Em = 495/520 nm) obtained by covalently coupling the green fluorescent dye fluorescein isothiocyanate (FITC) to the long-acting analogue of GLP-1, Semaglutide. | ||||
| GC79196 | Semaglutide, Cy5 labeled | - | >98% | |
Semaglutide, Cy5-labeled (Semaglutide-Cys(Cy5)) is a CY5 -labeled version of Semaglutide (Ex/Em = 633/670 nm). | ||||
